Dimensional Fund Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,664
| Closed | -$32K | – | 3395 |
|
|
2020
Q2 | $32K | Sell |
12,664
-2,469
| -16% | -$4.68K | ﹤0.01% | 3325 |
|
|
2020
Q1 | $19K | Sell |
15,133
-4,935
| -25% | -$10.1K | ﹤0.01% | 3354 |
|
|
2019
Q4 | $56K | Buy |
20,068
+6,445
| +47% | +$20.7K | ﹤0.01% | 3343 |
|
|
2019
Q3 | $73K | Sell |
13,623
-59,482
| -81% | -$396K | ﹤0.01% | 3366 |
|
|
2019
Q2 | $702K | Sell |
73,105
-21,496
| -23% | -$396K | ﹤0.01% | 3128 |
|
|
2019
Q1 | $2.54M | Sell |
94,601
-31,213
| -25% | -$794K | ﹤0.01% | 2835 |
|
|
2018
Q4 | $2.84M | Sell |
125,814
-67
| -0.1% | -$2.62K | ﹤0.01% | 2760 |
|
|
2018
Q3 | $6.95M | Buy |
125,881
+15,860
| +14% | +$1.01M | ﹤0.01% | 2573 |
|
|
2018
Q2 | $7.86M | Buy |
110,021
+18,384
| +20% | +$1.3M | ﹤0.01% | 2511 |
|
|
2018
Q1 | $5.63M | Buy |
91,637
+20,478
| +29% | +$1.8M | ﹤0.01% | 2595 |
|
|
2017
Q4 | $8.97M | Sell |
71,159
-1,931
| -3% | -$247K | ﹤0.01% | 2419 |
|
|
2017
Q3 | $10M | Buy |
73,090
+18,027
| +33% | +$2.41M | ﹤0.01% | 2375 |
|
|
2017
Q2 | $7.85M | Buy |
55,063
+23,348
| +74% | +$3.61M | ﹤0.01% | 2448 |
|
|
2017
Q1 | $5.83M | Buy |
31,715
+20,404
| +180% | +$2.29M | ﹤0.01% | 2509 |
|
|
2016
Q4 | $912K | Buy |
11,311
+9,648
| +580% | +$763K | ﹤0.01% | 2987 |
|
|
2016
Q3 | $127K | Buy |
1,663
+390
| +31% | +$31.2K | ﹤0.01% | 3217 |
|
|
2016
Q2 | $109K | Hold |
1,273
| – | – | ﹤0.01% | 3231 |
|
|
2016
Q1 | $118K | Buy |
+1,273
| New | +$127K | ﹤0.01% | 3224 |
|
Dimensional Fund Advisors's TTPH Position: Q3 2020 in Review
Dimensional Fund Advisors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 12,664 shares — an estimated $32K sold.
Dimensional Fund Advisors first reported a position in TTPH in Q1 2016 and held it in 18 quarters. The position peaked at $10M in Q3 2017. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Dimensional Fund Advisors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Dimensional Fund Advisors sold 12,664 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $32K.
- Dimensional Fund Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2016 and held it in 18 quarters.
- Dimensional Fund Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $10M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Dimensional Fund Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.